Assure

Impurities and adulterants in starting materials pose potential health threats when present in the manufacturing of pharmaceutical APIs and drug products. These same impurities and adulterants may also result in lower production yields and greater needs for product purification. Screening starting materials using Assure™ - Raw Material Screening identifies problem samples prior to use and prevents costly manufacturing mistakes. Designed for GMP environments, Assure - Raw Material Screening provides a traceable record of sample analysis and results. Applications extend beyond pharmaceutical production and includes chemical analysis.